N/A
N=67
Using Patient-Centered Guidelines in a Technology Platform to Improve Health Care in Adults With Sickle Cell Disease
Sickle Cell Disease
Bottom Line
View on ClinicalTrials.gov: NCT03629678 ↗Enrolled (actual)
67
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: SCD-specific Knowledge — 32.0; 32.0; 33.5; 33 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- mobile health application (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Vanderbilt University Medical Center
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY SCD-specific Knowledge |
32.0; 32.0; 33.5; 33 | — |
| SECONDARY Self-efficacy |
34.5; 32.5 | — |
| SECONDARY Healthcare Utilization (ER Visits and Hospitalizations) |
0; 0 | — |
| SECONDARY Usage and Usability of the mHealth Application |
56.2 | — |
| SECONDARY Patient Activation Measure |
73.8; 73.8 | — |
Summary
SCD is an inherited disorder of hemoglobin that affects over 100,000 Americans, most of whom live in low-resourced neighborhoods. Acute SCD complications result in 230,000 emergency department visits and $1.5 billion annually in acute-care expenditures. Prior research indicates that increased disease-specific knowledge correlates with improved clinical outcomes in SCD. Thus, targeting strategies to improve disease-specific knowledge is a high priority in the care of individuals with SCD. Significant evidence describes how educational materials, including online educational programs, can be used to increase disease-specific knowledge. In this study, the investigators will evaluate a mobile phone technology intervention based on the prior evidence that technologies can improve SCD-specific knowledge.
Eligibility Criteria
Inclusion Criteria
- receives care at the community health clinic,
- diagnosis of SCD (Hgb SS, SC, Sβ-thal),
- ability to speak and understand written English
- has access to a smartphone or computer
- between 18-70 years.
Exclusion Criteria
- lack of access to a smartphone or computer
- inability to speak and understand written English
Data sourced from ClinicalTrials.gov (NCT03629678). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.